These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 21031566)
21. Medicines pricing singled out. Buchanan E S Afr Med J; 2004 May; 94(5):334. PubMed ID: 15211941 [No Abstract] [Full Text] [Related]
22. Organic synthesis remains relevant in drug discovery. Mehrotra MM Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370 [No Abstract] [Full Text] [Related]
23. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
24. The regulation of drugs and biologics: fifty years into the future. Kuhlik BN Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358 [No Abstract] [Full Text] [Related]
25. Extortion and the ethics of "Topping Up". Sachs B Camb Q Healthc Ethics; 2009; 18(4):443-5. PubMed ID: 19739335 [No Abstract] [Full Text] [Related]
26. Prescriptions imported into the United States. Tenn Med; 2004 Aug; 97(8):337. PubMed ID: 15376708 [No Abstract] [Full Text] [Related]
27. Will spam overwhelm our defenses? Evaluating offerings for drugs and natural health products. Gernburd P; Jadad AR PLoS Med; 2007 Sep; 4(9):e274. PubMed ID: 17880258 [TBL] [Abstract][Full Text] [Related]
28. The Price of Precision: Genetic Testing and Drug Costs in America. Rich K; Terry SF Genet Test Mol Biomarkers; 2018 Jul; 22(7):403-404. PubMed ID: 30020834 [No Abstract] [Full Text] [Related]
29. Economic evaluation of pharmaceuticals. Massam D Pharmacoeconomics; 1992 Mar; 1(3):217. PubMed ID: 10172056 [No Abstract] [Full Text] [Related]
31. NerveCenter: FDA requirements for generic drug applications. Ann Neurol; 2010 Sep; 68(3):A11. PubMed ID: 20818779 [No Abstract] [Full Text] [Related]
32. Patent indicators: a window to pharmaceutical market success. Guo Y; Hu Y; Zheng M; Wang Y Expert Opin Ther Pat; 2013 Jul; 23(7):765-71. PubMed ID: 23611022 [TBL] [Abstract][Full Text] [Related]
33. Food and Drug Administration regulations and licensure. Barker LF Fed Proc; 1975 May; 34(6):1522-4. PubMed ID: 1126452 [TBL] [Abstract][Full Text] [Related]
34. Regulatory and Economic Considerations of Retinal Drugs. Shah AR; Williams GA Dev Ophthalmol; 2016; 55():376-80. PubMed ID: 26502165 [TBL] [Abstract][Full Text] [Related]
35. Initial steps in the regulation of generic biological drugs: a comparison of U.S. and Canadian regimes. Szeto KJ; Wolanski M Food Drug Law J; 2012; 67(2):131-41, i. PubMed ID: 24620416 [TBL] [Abstract][Full Text] [Related]
36. Pharmaceuticals and medical devices: cost savings. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891 [No Abstract] [Full Text] [Related]
37. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
38. The estimated impact of drug importation, mandatory mail service, and Medicaid fee reduction on community pharmacies in Michigan. McKercher PL J Manag Care Pharm; 2006 Mar; 12(2):157-63. PubMed ID: 16515374 [No Abstract] [Full Text] [Related]
39. Pharmaceutical companies should pay for raiding nature's medicine cabinet. Canning AD; Death RG; Waltham NJ Lancet; 2021 Sep; 398(10303):840-841. PubMed ID: 34390656 [No Abstract] [Full Text] [Related]